Predictors of methadone program non-retention for opioid analgesic dependent patients

Journal of Substance Abuse Treatment

Volumn 44, Issue 1, 2013, Pages 52-60

  Cox, Joseph ^a,b,c,d   Allard, Robert ^c,d   Maurais, Emilie ^c   Haley, Noreen ^a   Small, Chris ^a  

^a Cape Breton District Health Authority   (Canada)

^b CAPE BRETON UNIVERSITY   (Canada)

^c Montreal Health and Social Services Agency   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Health care utilization; Methadone maintenance program; Opioid analgesics; Treatment retention

Indexed keywords

HYDROMORPHONE; METHADONE; MORPHINE; NARCOTIC ANALGESIC AGENT; OXYCODONE; PERCOCET; SEDATIVE AGENT;

ARTICLE; DISEASE SEVERITY; FEMALE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NARCOTIC DEPENDENCE; PREDICTOR VARIABLE; PRIORITY JOURNAL; SEX RATIO; TREATMENT OUTCOME;

ADULT; ANALGESICS, OPIOID; CANADA; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METHADONE; MULTIVARIATE ANALYSIS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PATIENT COMPLIANCE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84870240662     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2012.03.002     Document Type: Article

References (53)

1. Amato L., Minozzi S., Davoli M., Vecchi S., Ferri M., Mayet S. Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cochrane Database of Systematic Reviews 2009, Retrieved from. http://onlinelibrary.wiley.com/o/cochrane/clsysrev/articles/CD004147/frame.html.
2. American Psychiatric Association Diagnostic and statistical manual of mental disorders: DSM-IV-TR 2000, Washington, DC. 4th ed.
3. Anderson J.F., Warren L.D. Client retention in the British Columbia Methadone Program, 1996-1999. Canadian Journal of Public Health 2004, 95:104-109.
4. Anglin M.D., Hser Y.I., Booth M.W. Sex differences in addict careers. 4. Treatment. American Journal of Drug and Alcohol Abuse 1987, 13:253-280.
5. Anglin M.D., Hser Y.I., Grella C.E. Drug addiction and treatment careers among clients in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors 1997, 11:308-323.
6. Babst D.V., Chambers C.D., Warner A. Patient characteristics associated with retention in a methadone maintenance program. British Journal of Addiction to Alcohol and Other Drugs 1971, 66:195-204.
7. Cacciola J.S., Rutherford M.J., Alterman A.I., McKay J.R., Snider E.C. Personality disorders and treatment outcome in methadone maintenance patients. Journal of Nervous and Mental Disease 1996, 184:234-239.
8. Cape Breton District Health Authority. (2005). Privacy Policy. Sydney, NS. Retrieved September 15, 2010, from http://www.cbdha.nshealth.ca/IC2/intranet/includes/secure_file.cfm?ID=33&menuID=6.
9. Caplehorn J.R., Bell J. Methadone dosage and retention of patients in maintenance treatment. Medical Journal of Australia 1991, 154:195-199.
10. Policy impact: prescription painkiller overdoses Center for Disease Control and Prevention, & National Center for Injury Prevention and Control, Retrieved December 1, 2011, from. http://www.cdc.gov/homeandrecreationalsafety/rxbrief/.
11. Center for Substance Abuse Research Increase in unintentional overdose deaths involving opioid analgesics mirror rise in per capita sales of these drugs. CESAR Fax 2011, 20. Retrieved from. http://www.cesar.umd.edu/cesar/cesarfax.asp.
12. Centre for Addictions Research of British Columbia Evidence review: Prevention of harms associated with substance use 2006, Population Health and Wellness, Ministry of Health, Victoria.
13. Cicero T.J., Surratt H., Inciardi J.A., Munoz A. Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States. Pharmacoepidemiology and Drug Safety 2007, 16:827-840.
14. CTV.ca News Staff 'Hillbilly heroin' takes strong hold on addicts Retrieved October 15, 2010, from. http://www.ctv.ca/servlet/ArticleNews/print/CTVNews/1077059340371_22/?hub=Health&subhub=PrintStory.
15. Deck D., Carlson M. Retention in publicly funded methadone maintenance treatment in two western states. Journal of Behavioral Health Services & Research 2005, 32:43-60.
16. Del Rio M., Mino A., Perneger T.V. Predictors of patient retention in a newly established methadone maintenance treatment programme. Addiction 1997, 92:1353-1360.
17. DeMaria P.A., Sterling R., Weinstein S.P. The effect of stimulant and sedative use on treatment outcome of patients admitted to methadone maintenance treatment. American Journal on Addictions/American Academy of Psychiatrists in Alcoholism and Addictions 2000, 9:145-153.
18. Eriksen J., Postnikoff L., Rhode L., Wurtz W. Guidelines for participation in the methadone program for Saskatchewan pharmacists 2001, Retrieved May 24, 2011, from http://www.napra.org/Content_Files/Files/Saskatchewan/PFM/Methadone_Program.pdf.
19. Faggiano F., Vigna-Taglianti F., Versino E., Lemma P. Methadone maintenance at different dosages for opioid dependence. Cochrane Database of Systematic Reviews 2008, Retrieved from. http://onlinelibrary.wiley.com/o/cochrane/clsysrev/articles/CD002208/frame.html.
20. Farre M., Mas A., Torrens M., Moreno V., Cami J. Retention rate and illicit opioid use during methadone maintenance interventions: A meta-analysis. Drug and Alcohol Dependence 2002, 65:283-290.
21. Fischer B., Rehm J. Illicit opioid use in the 21st century: Witnessing a paradigm shift?. Addiction 2007, 102:499-501.
22. Fischer B., Rehm J., Kim G., Kirst M. Eyes wide shut?-A conceptual and empirical critique of methadone maintenance treatment. European Addiction Research 2005, 11:1-14.
23. Fischer B., Rehm J., Patra J., Cruz M.F. Changes in illicit opioid use across Canada. CMAJ: Canadian Medical Association Journal = Journal de l'Association Medicale Canadienne 2006, 175:1385.
24. Gelberg L., Andersen R.M., Leake B.D. The behavioral model for vulnerable populations: Application to medical care use and outcomes for homeless people. Health Services Research 2000, 34:1273-1302.
25. Gillis C. Illicit Trade in Oxycontin Plagues Atlantic Provinces Retrieved October 15, 2010, from. http://www.thecanadianencyclopedia.com/index.cfm?PgNm=TCE&Params=M1ARTM0012610.
26. Gossop M., Marsden J., Stewart D., Treacy S. Outcomes after methadone maintenance and methadone reduction treatments: Two-year follow-up results from the National Treatment Outcome Research Study. Drug and Alcohol Dependence 2001, 62:255-264.
27. Greenfield S.F., Brooks A.J., Gordon S.M., Green C.A., Kropp F., McHugh R.K., Miele G.M. Substance abuse treatment entry, retention, and outcome in women: A review of the literature. Drug and Alcohol Dependence 2007, 86:1-21.
28. Grella C.E., Hser Y.I., Joshi V., Anglin M.D. Patient histories, retention, and outcome models for younger and older adults in DATOS. Drug and Alcohol Dependence 1999, 57:151-166.
29. Hosmer D.W., Lemeshow S. Applied logistic regression 1989, John Wiley & Sons Ltd, New York.
30. Interagency Secretariat on Research Ethics Tri-Council Policy Statement 2005, Ethical Conduct for Research Involving Humans, Ottawa, ON.
31. Leclerc P., Roy E., Morissette C., Alary M., Parent R. Extent and correlates of injection of prescription opioids for non-medical purposes in the SurvUDI network. Oral Presentation (Abstract #O048) 2011, SurvUDI Working Group.
32. Lehmann F., Lauzon P., Amsel R. Methadone maintenance: Predictors of outcome in a Canadian milieu. Journal of Substance Abuse Treatment 1993, 10:85-89.
33. Lewis J. Painting the picture of prescription drug abuse in Cape Breton: A baseline study 2006, Cape Breton University Press, Sydney, Nova Scotia.
34. Lu S.-H., Coleman D., Hedges D., Ouellette V., Reyes-Smith L., Sobey P. Stepping forward improving addiction care in British Columbia 2009, British Columbia Medical Association, Vancouver.
35. Luce J., Strike C.J. A cross-Canada scan of methadone maintenance treatment policy developments (Centre for Addiction and Mental Health, Trans.) 2010, Canadian Executive Council on Addictions, Ottawa.
36. Lunn M., McNeil D. Comparative study. Biometrics 1995, 51:524-532.
37. Magura S., Nwakeze P.C., Demsky S. Pre- and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction 1998, 93:51-60.
38. McLellan A.T., Luborsky L., Woody G.E., O'Brien C.P. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. Journal of Nervous and Mental Disease 1980, 168:26-33.
39. Pates R.M., McBride A.J., Ball N., Arnold K. Towards and holistic understanding of injecting drug use: An overview of needle fixation. Addiction Research & Theory 2001, 9:3-17.
40. Peles E., Schreiber S., Sason A., Adelson M. Earning "take-home" privileges and long-term outcome in a methadone maintenance treatment program. Journal of Addiction Medicine 2011, 5:92-98.
41. Petry N.M., Bickel W.K. Gender differences in hostility of opioid-dependent outpatients: Role in early treatment termination. Drug and Alcohol Dependence 2000, 58:27-33.
42. Selvin S. Statistical analysis of epidemiologic data (Vol. 2) 1996, Oxford University Press, New York.
43. Simpson D.D., Joe G.W., Broome K.M., Hiller M.L., Knight K., Rowan-Szal G.A. Program diversity and treatment retention rates in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors 1997, 11:279-293.
44. Simpson D.D., Joe G.W., Rowan-Szal G.A. Drug abuse treatment retention and process effects on follow-up outcomes. Drug and Alcohol Dependence 1997, 47:227-235.
45. Smythe C., Caverson R. Alcohol, other drugs and related harms in Ontario 2008, Centre for Addiction and Mental Health, Toronto.
46. Stevens A., Radcliffe P., Sanders M., Hunt N. Early exit: Estimating and explaining early exit from drug treatment. Harm Reduction Journal 2008, 5:13.
47. Strike C.J., Gnam W., Urbanoski K., Fischer B., Marsh D.C., Millson M. Factors predicting 2-year retention in methadone maintenance treatment for opioid dependence. Addictive Behaviors 2005, 30:1025-1028.
48. United Nations Office on Drugs and Crime. Reducing the harm of drug use and dependence. Retrieved July 25, 2011, from http://www.unodc.org/ddt-training/treatment/VOLUME%20D/Topic%204/1.VolD_Topic4_Harm_Reduction.pdf.
49. Vaillant G.E. Natural history of addiction and pathways to recovery. Principles of addiction medicine 2003, 3-16. American Society of Addiction Medicine, Inc, Chevy Chase. 3rd ed. A.W. Graham, T.K. Schultz, M.F. Mayo-Smith, R.K. Ries, B.B. Wilford (Eds.).
50. Villafranca S.W., McKellar J.D., Trafton J.A., Humphreys K. Predictors of retention in methadone programs: A signal detection analysis. Drug and Alcohol Dependence 2006, 83:218-224.
51. Weatherby N., Needle R., Cesari H., Booth R., McCoy C.B., Watters J.K., Chitwood D.D. Validity of self-reported drug use among injection drug users and crack cocaine users recruited through street outreach. Evaluation and Program Planning 1994, 17:347-355.
52. Weekes J. Fact sheet: Oxycontin (Oxycodone hydrochloride) Retrieved from. http://www.ccsa.ca/2006%20CCSA%20Documents/ccsa-003642-2006.pdf.
53. Wu L.T., Woody G.E., Yang C., Blazer D.G. How do prescription opioid users differ from users of heroin or other drugs in psychopathology: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Addiction Medicine 2011, 5:28-35.